Widely used:Recently Viewed
Clear All
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$575 Mln
P/E Ratio
18.67
P/B Ratio
2.22
Industry P/E
--
Debt to Equity
1.91
ROE
0.13 %
ROCE
8.79 %
Div. Yield
0.33 %
Book Value
1.98
EPS
0.66
CFO
$1,124.25 Mln
EBITDA
$1,337.35 Mln
Net Profit
$679.64 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Core Laboratories NV (CLB)
| -27.09 | -17.14 | -33.96 | -26.80 | -27.86 | 3.14 | -20.23 |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Core Laboratories NV (CLB)
| -12.88 | -9.14 | -15.84 | -29.63 | -36.86 | -45.36 | -8.74 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement... segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas. Address: 6316 Windfern Road, Houston, TX, United States, 77040 Read more
Chairman of the Board, CEO, President & COO
Mr. Lawrence V. Bruno
Chairman of the Board, CEO, President & COO
Mr. Lawrence V. Bruno
Headquarters
Houston, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Core Laboratories NV (CLB) stood at $ 590 Mln as on 31-Dec-24
The share price of Core Laboratories NV (CLB) is $12.62 (NYSE) as of 17-Apr-2025 16:10 EDT. Core Laboratories NV (CLB) has given a return of -27.86% in the last 3 years.
Core Laboratories NV (CLB) has a market capitalisation of $ 575 Mln as on 17-Apr-2025. As per Value Research classification, it is a company.
The P/E ratio of Core Laboratories NV (CLB) is 18.67 times as on 17-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Core Laboratories NV (CLB) and enter the required number of quantities and click on buy to purchase the shares of Core Laboratories NV (CLB).
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas. Address: 6316 Windfern Road, Houston, TX, United States, 77040
The CEO & director of Mr. Lawrence V. Bruno. is Core Laboratories NV (CLB), and CFO & Sr. VP is Mr. Lawrence V. Bruno.
There is no promoter pledging in Core Laboratories NV (CLB).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Core Laboratories NV (CLB) | Ratios |
|---|---|
|
Return on equity(%)
|
19.67
|
|
Operating margin(%)
|
11.18
|
|
Net Margin(%)
|
5.99
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Core Laboratories NV (CLB) was $31 Mln.
$0.30
(
